Aprea Therapeutics, Inc. (APRE) Net income 2017–2025
Aprea Therapeutics, Inc. (APRE) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$12.6MFY2025 · since FY2017: -$15.2M → -$12.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.6M | +2.8% |
| FY2024 | -$13.0M | +9.3% |
| FY2023 | -$14.3M | +87.3% |
| FY2022 | -$112.7M | -203.4% |
| FY2021 | -$37.1M | +30.6% |
| FY2020 | -$53.5M | -90.6% |
| FY2019 | -$28.1M | -80.7% |
| FY2018 | -$15.5M | -2.2% |
| FY2017 | -$15.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice